ArticleClinical and translational radiation oncology2019

The failure of cetuximab-based de-intensified regimes for HPV-positive OPSCC: A radiobiologists perspective.

Thorsten Rieckmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.